Hotline: 1800 102 2007
Hotline: 1800 102 2007
Dec, 30 2016

Zydus Cadila acquires six brands from MSD for an undisclosed amount

Zydus said that the deal includes transfer of distribution and commercialisation rights and assignment of trademarks of all the six brands to Zydus Healthcare Limited in India.

Zydus Cadila acquires six brands from MSD for an undisclosed amount

Ahmedabad-based Rs 10,000 crore drug major Zydus Cadila, through its wholly-owned subsidiary Zydus Healthcare Limited, has acquired six brands from global pharma major MSD and its subsidiaries for an undisclosed sum.

The brands include Deca-durabolin, Durabolin, Sustanon, Multiload, Sicastat and Axeten range, which fall in the men's health, women's health, cardiovascular and wound management therapy segments.

The company said in a statement that the deal includes transfer of distribution and commercialisation rights and assignment of trademarks of all the six brands to Zydus Healthcare Limited in India.

As part of the deal, Organon (India) Private Limited, one of the legal subsidiaries through which MSD operates its business in India, has also transferred the distribution and commercialisation rights for Deca-Durabolin and Durabolin to Zydus for Nepal. Merck is known as MSD outside the United States and Canada.

It operates in areas including prescription medicines, vaccines, biologic therapies and animal health products and has a presence across 140 countries. The financial details of the deal, however, remain undisclosed.

The acquired portfolio had clocked sales of Rs 84 crore in 2015. Analysts felt that the strategic brand acquisition would plug in gaps in Zydus' therapy portfolio, especially in the men's health portfolio where it had limited presence.

Sharvil Patel, Chairman of Zydus Healthcare Limited, said, "We have a long-standing association with MSD in India and value them as a partner. We look at this as a great opportunity to strengthen our core offerings to create value and growth."

Among other acquired brands, Multiload, an intra-uterine device is expected to widen the offerings the Group has in women's contraceptives segment. Axeten is a popular antihypertensive brand and Sicastat is used in wound management.

sharebtn
Comment
user
email
mobile
address
star
Related opportunities
  • Beauty Salons
    About Us: Apple Unisex Salon was incepted with a dream to..
    Locations looking for expansion Maharashtra
    Establishment year 2006
    Franchising Launch Date 2020
    Investment size Rs. 20lac - 30lac
    Space required 400
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater Pune Maharashtra
  • About Us: AHS is the fastest growing hospitality management/branding company in..
    Locations looking for expansion Delhi
    Establishment year 2008
    Franchising Launch Date 2019
    Investment size Rs. 5 Cr. above
    Space required 2090
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater New delhi Delhi
  • Preschools
    About Us: Pre School Franchise is a recession free business and..
    Locations looking for expansion Karnataka
    Establishment year 2017
    Franchising Launch Date 2019
    Investment size Rs. 10lac - 20lac
    Space required 1500
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater Bangalore Karnataka
  • About Us:  The Dewan School, true to its Motto, has grown..
    Locations looking for expansion Uttar pradesh
    Establishment year 2010
    Franchising Launch Date 2019
    Investment size Rs. 2lac - 5lac
    Space required -NA-
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater Meerut Uttar pradesh
Insta-Subscribe to
Entrepreneur
Magazine
sme-80x109
For hassle free instant subscription, just give your number and email id and our customer care agent will get in touch with you
email
mobile
OR Click here to Subscribe Online
Daily Updates
Submit your email address to receive the latest updates on news & host of opportunities